< 0 1 0 1 O
/=18 1 5 1 5 O
years 6 11 6 11 I-upper_bound

Anticoagulation 0 15 12 27 B-treatment
other 16 21 28 33 O
than 22 26 34 38 O
ASA 27 30 39 42 B-treatment

Creatinine 0 10 43 53 B-clinical_variable
> 11 12 54 55 O
2.0 13 16 56 59 B-lower_bound
mg 17 19 60 62 I-lower_bound
/ 19 20 62 63 I-lower_bound
dl 20 22 63 65 I-lower_bound

Fasting 0 7 66 73 B-clinical_variable
C 8 9 74 75 I-clinical_variable
- 9 10 75 76 I-clinical_variable
peptide 10 17 76 83 I-clinical_variable
level 18 23 84 89 I-clinical_variable
> 24 25 90 91 O
0.3 26 29 92 95 O
ng 30 32 96 98 O
/ 32 33 98 99 O
ml 33 35 99 101 O

Hemoglobin 0 10 102 112 B-clinical_variable
< 11 12 113 114 O
10 13 15 115 117 B-upper_bound
g 16 17 118 119 I-upper_bound
/ 17 18 119 120 I-upper_bound
dl 18 20 120 122 I-upper_bound

Known 0 5 123 128 O
active 6 12 129 135 B-chronic_disease
infection 13 22 136 145 I-chronic_disease

Must 0 4 146 150 O
have 5 9 151 155 O
a 10 11 156 157 O
blood 12 17 158 163 O
test 18 22 164 168 O
confirming 23 33 169 179 O
the 34 37 180 183 O
presence 38 46 184 192 O
of 47 49 193 195 O
at 50 52 196 198 O
least 53 58 199 204 O
one 59 62 205 208 B-lower_bound
autoantibody 63 75 209 221 O
to 76 78 222 224 O
pancreatic 79 89 225 235 O
islet 90 95 236 241 O
cells 96 101 242 247 O
( 102 103 248 249 O
IAA 103 106 249 252 O
, 106 107 252 253 O
IA2 108 111 254 257 O
, 111 112 257 258 O
GAD 113 116 259 262 O
65 117 119 263 265 O
, 119 120 265 266 O
ZnT8 121 125 267 271 O
) 125 126 271 272 O

Must 0 4 273 277 O
have 5 9 278 282 O
a 10 11 283 284 O
diagnosis 12 21 285 294 O
of 22 24 295 297 O
type 25 29 298 302 B-chronic_disease
1 30 31 303 304 I-chronic_disease
diabetes 32 40 305 313 I-chronic_disease
mellitus 41 49 314 322 I-chronic_disease
based 50 55 323 328 O
on 56 58 329 331 O
the 59 62 332 335 O
2015 63 67 336 340 O
American 68 76 341 349 O
Diabetes 77 85 350 358 O
Association 86 97 359 370 O
criteria 98 106 371 379 O
for 107 110 380 383 O
the 111 114 384 387 O
Clarification 115 128 388 401 O
and 129 132 402 405 O
Diagnosis 133 142 406 415 O
of 143 145 416 418 O
diabetes 146 154 419 427 O

Pregnancy 0 9 428 437 B-pregnancy

Presence 0 8 438 446 O
of 9 11 447 449 O
any 12 15 450 453 O
other 16 21 454 459 O
autoimmune 22 32 460 470 B-chronic_disease
diseases 33 41 471 479 I-chronic_disease
( 42 43 480 481 O
lupus 43 48 481 486 B-chronic_disease
, 48 49 486 487 O
rheumatoid 50 60 488 498 B-chronic_disease
arthritis 61 70 499 508 I-chronic_disease
, 70 71 508 509 O
scleroderma 72 83 510 521 B-chronic_disease
, 83 84 521 522 O
etc 85 88 523 526 O
. 88 89 526 527 O
) 89 90 527 528 O

Use 0 3 529 532 O
of 4 6 533 535 O
immunosuppressive 7 24 536 553 B-treatment
medication 25 35 554 564 I-treatment
within 36 42 565 571 O
one 43 46 572 575 B-upper_bound
month 47 52 576 581 I-upper_bound
of 53 55 582 584 O
enrollment 56 66 585 595 O
including 67 76 596 605 O
but 77 80 606 609 O
not 81 84 610 613 O
limited 85 92 614 621 O
to 93 95 622 624 O
prednisone 96 106 625 635 B-treatment
, 106 107 635 636 O
cyclosporine 108 120 637 649 B-treatment
, 120 121 649 650 O
tacrolimus 122 132 651 661 B-treatment
, 132 133 661 662 O
sirolimus 134 143 663 672 B-treatment
, 143 144 672 673 O
and 145 148 674 677 O
chemotherapy 149 161 678 690 B-treatment

platelets 0 9 691 700 B-clinical_variable
< 10 11 701 702 O
100 12 15 703 706 B-upper_bound
k 16 17 707 708 I-upper_bound
/ 17 18 708 709 I-upper_bound
ml 18 20 709 711 I-upper_bound

